CY1119957T1 - Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος - Google Patents
Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματοςInfo
- Publication number
- CY1119957T1 CY1119957T1 CY20181100232T CY181100232T CY1119957T1 CY 1119957 T1 CY1119957 T1 CY 1119957T1 CY 20181100232 T CY20181100232 T CY 20181100232T CY 181100232 T CY181100232 T CY 181100232T CY 1119957 T1 CY1119957 T1 CY 1119957T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- announced
- patients
- pharmaceutical preparation
- preparations
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305009 | 2013-01-07 | ||
| EP14700238.0A EP2941257B1 (de) | 2013-01-07 | 2014-01-07 | Krankheitstherapie mit einer tolerogenen pharmazeutischen zubereitung |
| PCT/EP2014/050167 WO2014106666A1 (en) | 2013-01-07 | 2014-01-07 | Disease therapy using a tolerogenic pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119957T1 true CY1119957T1 (el) | 2018-12-12 |
Family
ID=47559360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100232T CY1119957T1 (el) | 2013-01-07 | 2018-02-27 | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10653758B2 (de) |
| EP (1) | EP2941257B1 (de) |
| CY (1) | CY1119957T1 (de) |
| DK (1) | DK2941257T3 (de) |
| ES (1) | ES2657675T3 (de) |
| HR (1) | HRP20180359T1 (de) |
| HU (1) | HUE038211T2 (de) |
| LT (1) | LT2941257T (de) |
| NO (1) | NO2941257T3 (de) |
| PL (1) | PL2941257T3 (de) |
| PT (1) | PT2941257T (de) |
| RS (1) | RS56906B1 (de) |
| SI (1) | SI2941257T1 (de) |
| WO (1) | WO2014106666A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016221305B2 (en) | 2015-02-18 | 2021-05-27 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| CN107708811B (zh) * | 2015-04-21 | 2021-04-30 | 恩立夫克治疗有限责任公司 | 治疗性汇集的血液凋亡细胞制剂与其用途 |
| CA3014885A1 (en) | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
| FR3082730B1 (fr) * | 2018-06-21 | 2022-04-22 | Med Inn Pharma | Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202098A1 (en) * | 2001-01-31 | 2005-09-15 | Tolaren | Disease therapy using dying or dead cells |
| JP2008539751A (ja) * | 2005-05-10 | 2008-11-20 | アヴァリス・アーベー | 新規組成物およびその使用 |
| CA2664567C (en) * | 2006-10-04 | 2016-04-26 | Dana-Farber Cancer Institute, Inc. | Tumor immunity |
| EP2201954A1 (de) | 2008-12-18 | 2010-06-30 | Aposcience AG | Pharmazeutisches Präparat |
-
2014
- 2014-01-07 WO PCT/EP2014/050167 patent/WO2014106666A1/en active Application Filing
- 2014-01-07 LT LTEP14700238.0T patent/LT2941257T/lt unknown
- 2014-01-07 SI SI201430584T patent/SI2941257T1/en unknown
- 2014-01-07 NO NO14700238A patent/NO2941257T3/no unknown
- 2014-01-07 PL PL14700238T patent/PL2941257T3/pl unknown
- 2014-01-07 DK DK14700238.0T patent/DK2941257T3/en active
- 2014-01-07 RS RS20180211A patent/RS56906B1/sr unknown
- 2014-01-07 US US14/759,452 patent/US10653758B2/en active Active
- 2014-01-07 ES ES14700238.0T patent/ES2657675T3/es active Active
- 2014-01-07 HU HUE14700238A patent/HUE038211T2/hu unknown
- 2014-01-07 PT PT147002380T patent/PT2941257T/pt unknown
- 2014-01-07 EP EP14700238.0A patent/EP2941257B1/de active Active
-
2018
- 2018-02-27 CY CY20181100232T patent/CY1119957T1/el unknown
- 2018-02-27 HR HRP20180359TT patent/HRP20180359T1/hr unknown
-
2020
- 2020-04-14 US US16/847,829 patent/US11793865B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200237884A1 (en) | 2020-07-30 |
| ES2657675T3 (es) | 2018-03-06 |
| HUE038211T2 (hu) | 2018-10-29 |
| LT2941257T (lt) | 2018-02-26 |
| PL2941257T3 (pl) | 2018-05-30 |
| US10653758B2 (en) | 2020-05-19 |
| RS56906B1 (sr) | 2018-05-31 |
| EP2941257B1 (de) | 2017-11-29 |
| NO2941257T3 (de) | 2018-04-28 |
| WO2014106666A1 (en) | 2014-07-10 |
| HRP20180359T1 (hr) | 2018-05-04 |
| SI2941257T1 (en) | 2018-03-30 |
| US20150343039A1 (en) | 2015-12-03 |
| US11793865B2 (en) | 2023-10-24 |
| PT2941257T (pt) | 2018-03-06 |
| EP2941257A1 (de) | 2015-11-11 |
| DK2941257T3 (en) | 2018-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
| CY1123845T1 (el) | Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων | |
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1120862T1 (el) | Παραγοντες επαγωγης αποπτωσης για τη θεραπευτικη αγωγη καρκινου και ανοσων και αυτοανοσων ασθενειων | |
| CY1119058T1 (el) | Ενωσεις ιμιδαζοπυρρολιδινονης | |
| EA201891186A1 (ru) | Антитела, нейтрализующие вирус иммунодефицита человека | |
| EA201890204A1 (ru) | Антибактериальные соединения | |
| CY1121736T1 (el) | Άλατα aramchol | |
| EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201500207A1 (ru) | Гетероароматические соединения в качестве ингибиторов втк | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| EA201591887A1 (ru) | Макроциклические деазаоксипурины для лечения вирусных инфекций | |
| EA201500383A1 (ru) | Производные 1,2,4-триазина для лечения вирусных инфекций | |
| TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
| BR112017000898A2 (pt) | oritavancina de alta pureza e método de produção da mesma | |
| EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
| CY1121105T1 (el) | Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv | |
| EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
| CL2015003431A1 (es) | Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales | |
| TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. | |
| CY1122708T1 (el) | Ενωσεις οξα-διαζασπειρο με δραση εναντι του πονου | |
| MD4763B1 (ro) | Compoziţie farmaceutică |